The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.
Sixty-nine-year-old Mary Anne Laporte was diagnosed with knee arthritis 15 years ago. For years, she kept the pain under control with steroid injections and physical therapy, but when she began ...
The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical ...
Researchers say new research findings might point to a major opportunity to act sooner to prevent rheumatoid arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback